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PoxnoPCOxidative stress leads to drastic modiﬁcations of both the biophysical properties of biomembranes and their
associated chemistry imparted upon the formation of oxidatively modiﬁed lipids. To this end, oxidized
phospholipid derivatives bearing an aldehyde function, such as 1-palmitoyl-2-(9'-oxo-nonanoyl)-sn-
glycero-3-phosphocholine (PoxnoPC) can covalently react with proteins that come into direct contact.
Intriguingly, we observed PoxnoPC in a 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) matrix to
shorten and abolish the lag time in the action of phospholipase A2 (PLA2) on this composite substrate, with
concomitant augmented decrement in pH, indicating more extensive hydrolysis, which was in keeping with
enhanced 90° light scattering. The latter was abolished by the aldehyde scavenger methoxyamine, thus
suggesting the involvement of Schiff base. Enhanced hydrolysis of a ﬂuorescent phospholipid analogue was
seen for PLA2 preincubated with PoxnoPC. Mixing PLA2 with submicellar (22 µM) PoxnoPC caused a
pronounced increase in Thioﬂavin T ﬂuorescence, in keeping with the formation of amyloid-type ﬁbers,
which were seen also by electron microscopy.sanyl-2-(pyren-1-yl)hexanoyl-
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Reactive oxygen species (ROS) result from cellular metabolism [1],
with increased levels observed in inﬂammation [2], as well as due to
external insults such as ultraviolet irradiation [3]. ROS rapidly oxidize
polyunsaturated fatty acids enriched in the sn-2 position of cellular
phospholipids. Oxidatively modiﬁed lipids are found in submicellar
concentrations in blood plasma, with elevated local concentrations
occurring at sites of inﬂammation [4]. Lipid peroxidation has been
shown to be associated with type 2 diabetes, Parkinson's and
Alzheimer's diseases, cancer [5–7], ischemia, schizophrenia [8],
acute pancreatitis ([9], and inﬂammatory diseases in general. Possible
mechanistic roles of oxidized lipids in these pathological conditions
are poorly understood, however. These lipids can have a number of
cellular effects viz. by impairment of ion transport mechanisms [10]resulting from modiﬁcation of the functions of proteins either via
direct interactions or by altering the physicochemical properties of
the lipid bilayer, further correlating to the membrane physiological
state and cellular pathology [11–13]. Further, their chemically
reactive groups can modify and inﬂuence the activity of membrane
proteins, as well as cause further oxidation of other biomolecules e.g.
lipids, proteins, nucleic acids [14].
Phospholipases A2 (PLA2) cleave the sn-2 acyl chain from
glycerophospholipids to yield lysophospholipids and free fatty acids
(FFA). They represent a ubiquitous group of enzymes serving a
number of functions, from toxicity of several venoms to phospholipid
metabolism, digestion, cellular signaling, and antimicrobial activity
[15]. Oxidized phospholipids have been proposed to be efﬁciently
degraded by PLA2 and these enzymes have been proposed to protect
membranes from peroxidation damage by preferentially cleaving the
oxidized phospholipid species [16]. In accordance, phospholipid
oxidation upon UV radiation has been shown to induce PLA2. More
speciﬁcally, UV light causes erythema in human skin, mediated in part
by derivatives of arachidonic acid. PLA2 activity was found to increase
2- to 4-fold compared to control and the UV induced fatty acid release
was inhibited upon incubation with a polyclonal anti-phospholipase
A2 antibody [3].
The hallmark of lipolytic enzymes, including PLA2, is the so-called
interfacial activation: compared to the hydrolysis of monomeric
substrates their activity is dramatically enhanced when reacting with
phospholipid interfaces [17], such as those present in micelles,
monolayers, and bilayers. PLA2 appears to sense changes in the
physicochemical properties induced in the membrane by oxidized
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facilitating catalytic access to the sn-2 ester bond [18]. The
involvement of extended conformation [19] with the oxidized chain
protruding out of the membrane [20] is in keeping with the
preferential hydrolysis of oxidized phosphatidylcholine in mem-
branes containing cholesterol, making them better accessible to PLA2
[21]. The above results support the substratemodel of PLA2 activation,
assigning the activation to the physicochemical properties of the
interface [22] in this case imparted by the oxidized phospholipids. The
enzyme model assumes a change in the PLA2 conformation to be
induced by the interface [23]. Changes in PLA2 conformation upon
interfacial activation were recently demonstrated using FTIR and it
was suggested that enzyme conformational alterations, in unisonwith
the physical state of the substrate, would cause the augmented
catalytic activity [24,25].
The burst in PLA2 activity has been concluded to involve
dimerization [26,27] and aggregation of PLA2 [27,28]. The latter was
demonstrated also in DPPCmonolayers [29,30] and was triggered by a
lateral segregation at a critical mole fraction (X=0.08) of the reaction
products FFA and lysoPC [31]. We have recently characterized this
aggregation of PLA2 at burst in more detail [32]. Amyloid like ﬁbers
staining with Congo Red and thioﬂavin T were observed in vitro for
PLA2 upon the hydrolysis of phosphatidylcholine and we proposed a
scheme with highly active protoﬁbrils of PLA2 existing transiently
before the formation of inactive amyloid ﬁbrils, this process acting as a
thermodynamic on–off switch controlling enzyme catalytic activity
[32]. These ﬁbrillar structures have been recently demonstrated by
atomic force microscopy and ﬂuorescence microscopy of PLA2 acting
on supported DPPC bilayers [33,34]. Protein–protein interaction and
peptide-protein heteroligomerization were observed to accompany
the activation of PLA2 by the antimicrobial peptide temporin B, with
the hydrolytic products being required for the formation of peptide-
PLA2 coﬁbers [35].
Here we explored the interaction between PLA2 and the oxidized
phospholipid 1-palmitoyl-2-(9′-oxo-nonanoyl)-sn-glycero-3-
phosphocholine (PoxnoPC) in vitro. PoxnoPC arises from the peroxida-
tion of a polyunsaturated fatty acid such as linoleic acid 18:2(n-6) at the
sn-2 position. The truncation of the oxidatively modiﬁed sn-2 acyl
decreases its effective length, thus increasing the free volume available
for the sn-1 chain. The polar aldehyde moiety at the terminus of the
oxidatively modiﬁed acyl chain loops back and resides in the interface
or extends in the aqueous phase [20]. Increased PLA2 activity is evident
in the presence of PoxnoPC and appears to involve a chemical
modiﬁcation of the enzyme by the single aldehyde moiety of this
lipid forming a Schiff base with an amino group of PLA2. We further
show that PoxnoPC below its CMC triggers the formation of amyloid-
type ﬁbers while above the CMC this is not seen. PoxnoPC is suggested
to promote nucleation of amyloid-like ﬁbrils. However, the conversion
into inactive oligomers appears to be slowed down so that the enzyme
is maintained longer as highly catalytically active intermediate
protoﬁbrils, sustaining the expression of the enzyme catalytic activity.
2. Materials and methods
2.1. Materials
DPPC, lysoPC and PoxnoPC were from Avanti Polar Lipids
(Alabaster, AL). The purities of these lipids were checked by thin
layer chromatography on silicic acid coated plates (Merck, Darmstadt,
Germany) developed with a chloroform/methanol/water mixture
(65:25:4, v/v/v). Examination of the plates after iodine staining
revealed no impurities. Bee venom PLA2 was from Sigma and its
purity was veriﬁed by SDS PAGE. All other chemicals were of
analytical grade and from standard sources. Concentrations of the
lipid stock solutions in chloroform were determined gravimetrically
with a high-precision electrobalance (Cahn, Cerritos, CA), as describedin detail by Zhao et al. [36]. Freshly deionized ﬁltered water (Milli RO/
Milli Q, Millipore Inc., Jeffrey, NH) was used in all experiments.
CaCl2 solution was prepared and ﬁltered through a 0.02 µM ﬁlter
(Schleicher & Shuell Microscience, Dassel, Germany) prior to use.
2.2. Preparation of liposomes
Appropriate amounts of the stock solutions of the indicated lipids
in chloroform were transferred into carefully cleaned glass vials. The
solvent was removed under a stream of nitrogen and the lipid residue
was subsequently maintained under reduced pressure for at least 2 h.
The dry lipids were then hydrated at 60 °C in 5 mM Hepes, 0.1 mM
EDTA, pH 7.4, as indicated. To obtain LUVs the dispersions of 1 mM
were extruded through 0.1 µM ﬁlters, yielding 100 nm average
diameters measured by DLS (Zeta Sizer, Malvern, UK). For neat
PoxnoPC the resulting dispersions were kept for 1 h in a bath type
sonicator (NEY Ultrasonik, Bloomﬁeld, CT).
2.3. Measurement of the lag time γ in the action of PLA2 on DPPC
liposomes
For PLA2 acting on saturated phosphatidylcholines such as 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) in the vicinity of the
substrate phospholipid main phase transition the initial reaction rate
following the enzyme addition is very slow. After the lag (deﬁned as the
latency period between the addition of the enzymeand the burst), there
is an increase in the catalytic rate. Upon the PLA2 catalyzed hydrolysis a
proton is released for each produced free fatty acid and lysoPC.
Accordingly, the sudden acceleration of the acidiﬁcation of themedium
as a consequence of PLA2 action provides a convenient measure for
recording the burst in activity and has been extensively used by
laboratories investigating this property of PLA2s [26,32]. Importantly, as
we only wanted to observe the lag time the decrement in pH was not
corrected by titrationwith a base. The lagwas determined bymeasuring
the acidiﬁcation of the medium with a miniature pH electrode
(Microelectrodes, Bedford, NH) inserted into the ﬂuorescence cuvette
(see below). The burstwasdeﬁned as the intersectionpoint of the linear
ﬁts to the pH curve during the lag and the initial phase of rapid
hydrolysis. As an independent veriﬁcation of the burst in the PLA2
reaction, changes in 90° light scattering were observed using a
spectroﬂuorometer [26,32,35] with the excitation and emission
wavelengths set at 600 nm and using 1.5 nm bandpasses.
2.4. Fluorescence measurements
To assess PLA2 oligomerization in the presence of PoxnoPC we used
ThTﬂuorescence enhancement assay. PLA2 (3.8 µMﬁnal concentration)
was added to 10, 22, 40 µM of PoxnoPC and 6 µM ThT in 20 mMHepes,
0.1 mM EDTA, pH 7.4, in a total volume of 1 ml maintained at 37 °C in a
four walled cuvette with stirring. ThT ﬂuorescence was recorded with
λex=450 nm λem=482 with bandpasses of 2.5 nm and 10 nm,
respectively. A control with protein and ThT was also included. As a
further control we used 10 µM lysoPC. Thioﬂavin T staining belongs to
the standard tools in amyloid research. For review see [37–39]. Upon
binding of ThT to the cross beta-sheet protein ThT emission red shifts
from a weak ﬂuorescence (not bound to beta sheet) with maxima at
λex=342 nm to λem=430 nm to (bound to beta sheet) λex=450 nm
and λem=482 nm.
Fluorescently labeled PLA2 was prepared by coupling Alexa488
and Alexa568 to bee venom PLA2, to obtain PLA2D (donor) and PLA2A
(acceptor) as described previously [32]. Emission from ﬂuorescently
labeled PLA2 (PLA2A) was measured in a four-walled cuvette with
excitation and emission bandpasses of 5 and 10 nm, respectively.
When indicated, energy transfer between a FRET pair of labeled PLA2
(PLA2A and PLA2D) was observed. For this utility, we monitored FRET
channel with λex=460 nm and λem=600 nm, PLA2A (acceptor
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PLA2D with λex=460 nm and λem=520 nm. Final concentration of
lipid was 10 µM of PoxnoPC and ﬁnal concentration of protein was
300 nM, with 1:1 molar ratio of PLA2D and PLA2A (61% and 68%
labeling efﬁciency, respectively). The protein and lipid were added to
1 mL of 20 mMHepes, 0.1 mMEDTA, pH 7.4, at 37 °C andwith stirring.
2.4.1. Assay for PLA2 activity
PLA2 activity was determined by the kinetic assay described
previously [40–43]. Appropriate amounts of the stock solution of the
pyrene-labelled PLA2 substrate C28-0-PHPM in isopropanol:toluene
(1:2)were dried under a streamof nitrogen followed byhigh vacuum for
a minimum of 2 h. The lipid residues were subsequently dissolved in
ethanol to yield a lipid concentration of 50 μM, and this ethanolic lipid
solution was rapidly injected into the buffer in ﬁve 10 µl aliquots. The
ﬁnal lipid concentration was 1.25 μM C28-OPHPM in a total volume of
2 ml. All ﬂuorescence measurements were performed in magnetically
stirred quartz cuvettes (with 1-cm path length) at 37 °C. After 5 min of
equilibration the reactions were initiated (indicated by an arrow) by
adding bee venom PLA2 (2 nM ﬁnal protein concentration). When
indicated PoxnoPC or lysoPC at 10 µM (ﬁnal lipid concentration) was
mixedwith 2 nM of PLA2 and preincubated for 5 min before starting the
reaction. The progress of phospholipid hydrolysis was followed by
measuring the pyrene monomer intensity at 400 nm as a function of
time. Fluorescence intensities were measured with a Varian Carey
spectrometer with excitation at 344 nm, and emission at 400 and
480 nm, with both emission and excitation bandpasses set at 5 nm. The
assaywas calibratedbyaddingknownpicomolar aliquots of (pyren-1-yl)
hexanoate into the reaction mixture in the absence of enzyme while
detecting pyrene monomer emission intensity. The activity of the
enzymewas calculated fromthe increment inpyrenemonomeremission
and converted to the amount of product released per time in 1 mL.
2.5. Light scattering
Scattering was measured at 90° angle using a spectraﬂuorometer,
with excitation and emission bandpasses of 1.5 nm in a four window
quartz cuvette with λex=600 nm and λem=600 nm. Final concen-Fig. 1. Effect of PoxnoPC on the lag time of phospholipase A2 acting on DPPC. The hydrolysis o
and changes in 90° light scattering (panel B). Temperature was maintained at 37 °C. Th
concentration) into a total volume of 1 ml of 200 µM of DPPC (black) with X=0.05 (red), otrations of PoxnoPC and PLA2 were 10 and 3.8 µM, respectively.
Protein and lipid were added to 20 mM Hepes pH 7.4, 0.1 mM EDTA,
with and without 15 µM methoxyamine at 37 °C with stirring.
2.6. Electron microscopy
Aliquots from the scattering experiments were incubated for at
least 24 h and spun at 6000 rpm for 10 min in a benchtop centrifuge
(Heraeus Christ, Germany). Pellets were resuspended in buffer and
observed under an inverted microscope (Zeiss IM-35, Jena, Germany)
prior to electron microscopy experiment. Fibril formation was
assessed using 3 µl of sample placed on a 200-mesh copper grid
covered by carbon-stabilized Formvar ﬁlm. After 1 min, excess ﬂuid
was removed, and the grid was then negatively stainedwith 2% uranyl
acetate in water. After 30 s, excess ﬂuid was removed from the grid.
Samples were viewed in FEI Tecnai F12 (Philips Electron Optics,
Holland) electronmicroscope operating at 80 kV. Films were digitized
on a Gatan Multiscan 794 1 k×1 k CCD camera (Gatan Inc., USA).
3. Results
Similarly to other PLA2s bee venom phospholipase A2 shows a
distinct lag when acting on DPPC [32,35], and under the conditions
employed here (viz. 38 °C, 200 µM lipid, 75 nM protein ﬁnal
concentration) a latency period of about 11 min is observed (Fig. 1,
panel A). Addition of PoxnoPC decreases the lag time and with
X=0.05 PoxnoPC a latency time of 6 min is evident (Fig. 1, panel A). A
further decrease is seen with X=0.10 PoxnoPC, with lag being no
longer discernible. The ﬁnal pH reached in the presence of PoxnoPC is
lower than for neat DPPC LUV. Accordingly, pH decreases from 7.15 to
7.0 for neat DPPC, while with X=0.05 and X=0.10 PoxnoPC
decrements from 7.2 to 6.95 and 6.90, respectively, were evident,
revealing more extensive hydrolysis.
Subsequent to the burst, following the onset of rapid hydrolysis the
vesicles disrupt and the lipid organization changes dramatically with
development of a complex and poorly understood polymorphism [44–
46]. Without structural information on the lipid organization in this
phase quantitative data on the degree of hydrolysis [45] would havef the DPPC substrate wasmonitored as a function of time by the decrease in pH (panel A)
e reactions were started by the addition (marked by arrows) of 75 nM PLA2 (ﬁnal
r X=0.10 PoxnoPC (green) in 1 mM CaCl2.
Fig. 3. Activity of 2 nM phospholipase-A2 towards C28-0-PHPM (○) as a function of time
and for PLA2 preincubated (for 5 min before starting the reaction) with 10 µM PoxnoPC
(●) or 10 µM lysoPC (■) (ﬁnal lipid concentrations in preincubation). Reaction mixture
contained 1.25 µMC28-0-PHPM in 2.0 ml of 5 mMHepes, 0.1 mMEDTA, 1 mMCaCl2, pH
7.4 at 37 °C with stirring. Each point represents the average of four independent
experiments, with error bars giving the standard deviation. The symbols are not
individual data points but only one point out of 100. The continuous lines connect each
depicted experimental data point.
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Optically, this reorganization is evident as a pronounced increase in light
scattering after the burst e.g. [47,48]. The scattering shows a sharp
increase prior to the burst in activitymeasured by proton release (Fig. 1,
panel B). A faster initial increase in 90° light scattering is observedwith
PoxnoPC of X=0.05 and X=0.10, with a more prominent overall
increase when compared to LUVs without the oxidized phospholipid
(Fig. 1).
The burst in the catalytic activity is accompanied by ThT
ﬂuorescence enhancement suggesting amyloid-type oligomerization,
in keeping with the subsequent formation of Congo red staining
birefringent ﬁbrils [32]. Interestingly, for PoxnoPC/DPPC LUV an
augmented ThT ﬂuorescence is observed during the reaction (Fig. 2,
panels A and B). It is also seen that in the presence of ThT there is no
lag already at XPoxno=0.05. This could reﬂect amyloid-type oligo-
merization being promoted by ThT itself [49].
As a control we preincubated PLA2 with 10 µM PoxnoPC for 5 min,
before adding to a pyrene labeled phospholipid substrate (Fig. 3). This
preincubation increased the initial PLA2 activity and also enhanced
the overall hydrolysis (Fig. 3). In contrast when PLA2 was preincu-
bated with 10 µM lysoPC inhibition of the reaction was seen and the
maximum extent of hydrolysis after 60 min was reduced by 30%
(Fig. 3). The time to reach steady-state reaction rate was also shorter
for PLA2 preincubated with lysoPC.
Covalent adducts have been reported to form between PoxnoPC and
lysine residues of polypeptides [50–52]. We have previously demon-
strated the aldehyde group of PoxnoPC reacts with several host defense
peptides, with inhibition by methoxyamine suggesting Schiff base
formation [53]. PLA2 has 11 lysines located on its surface, with some of
them at the proposed interfacial region, suggested to be involved in the
binding of PLA2 to the substrate membrane interface [54–56]. Intense
scattering was observed at 10 µM PoxnoPC after the addition of 3.8 µM
of PLA2 (Fig. 4). With increasing concentrations of methoxyamine
decrease in scattering was observed, with a total lack of scattering
observed at a 1.5:1 molar ratio of methoxyamine to PoxnoPC (Fig. 4).
Several studies have demonstrated PLA2 activation to be accom-
panied by the formation of enzyme aggregates [26–28,32,35]. We
showed that during the lag of PLA2 acting on DPPC there is a slowFig. 2. Augmented ThT ﬂuorescence during the burst of PLA2 activity as monitored by decrea
Thioﬂavin T (6 µM) emission over time (panel B). Otherwise conditions were as in Fig. 1.increase in FRET revealing interaction between the donor (PLA2D)
and acceptor ﬂuorophore (PLA2A) labeled enzymes, peaking at the
burst [32]. After the burst, however, FRET decreased rapidly. In this
study we observed in the presence of submicellar PoxnoPC a decrease
in FRET (Fig. 5), followed after several hours by the emergence of
sudden ﬂuctuations in FRET. The loss of FRET is probably due to
protein oligomerization resulting in an ordered amyloid-like struc-
ture, in turn organizing the dyemolecules, causing charge (excitation)
delocalization, revealing that the oligomers are an ordered structure
rather than an amorphous aggregate.se in pH (panel A). Excitation was at λex=450 nm and λem=482 nm for the increase in
Fig. 4. 90 °C light scattering for PLA2 with 10 µM of PoxnoPC (○) as such, and in the
presence of 15 µM methoxyamine (●). Excitation and emission were both at 600 nm.
Reactions were monitored as a function of time and were started by the addition of
3.8 µM PLA2 in 20 mM Hepes, 0.1 mM EDTA, pH 7.0, 37 °C.
Fig. 6. ThT ﬂuorescence with time in the presence of PLA2 and PoxnoPC at con-
centrations below (black, 10 µM), at (red, 22 µM), and above (green, 40 µM) the CMC of
this lipid. Excitation was at λex=450 nm and λem=482 nm. Reactions were observed
at 37 °C after the addition of 3.8 µM PLA2 (ﬁnal concentration) to 6 µM ThT in 20 mM
Hepes, 0.1 mM EDTA, pH 7.0. Also shown is ThT ﬂuorescence trace recorded with PLA2
in the absence of PoxnoPC (blue), as well as in the presence of 10 µM lysoPC (cyan).
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formation in the presence of oxidized phospholipids [57,58]. Below
their critical micelle concentration (CMC) detergents, lysophospho-
lipids, and short-chain phospholipids promote amyloid formation
[59]. We used 10, 22, and 40 µM PoxnoPC corresponding to the
submicellar, CMC, and above CMC concentrations, respectively, for
this lipid [60]. PLA2 in the presence of 10 µM PoxnoPC showed a 2.5-
fold enhancement of ThT ﬂuorescence after 25 h (Fig. 6), while a 1.7-
fold increase was evident with 22 µM PoxnoPC (at the CMC) during
the same period. However, above the CMC at 40 µM no ﬂuorescence
enhancement was seen. As a control and to account for the effect of
ThT CMC [61] this experiment was done also in the absence of
PoxnoPC. ThT at its CMC (6 µM) did enhance the ﬂuorescence, yet lessFig. 5. Time course for FRET between PLA2D and PLA2A in the presence of PoxnoPC
monitored as a function of time. Emission of PLA2D at λ=520 nm upon excitation at
λex=460 nm (donor channel), emission of PLA2A at λem=600 nm upon excitation at
λex=460 nm for PLA2D (FRET channel) and excitation at λex=560. PLA2D and PLA2A
(total protein 300 nM: 150 nM bvPLA2D 61% labeled; and 150 nM, bvPLA2A 68.5%
labeled) were added to 10 µM PoxnoPC in 20 mM Hepes, 0.1 mM EDTA, pH 7.4, with
stirring in a four walled cuvette at 37 °C.than the enhancement obtained in the presence of 22 µM PoxnoPC. As
another control we used lysoPC which has similar effective shape as
PoxnoPC. Below its CMC lysoPC promoted amyloid formation but less
than PoxnoPC at the same concentration (Fig. 6). The formation of
amyloid-type ﬁbrils by PLA2 in the presence of submicellar PoxnoPC
was conﬁrmed by electron microscopy. The samples from scattering
experiments (Fig. 4) were centrifuged and then transferred into 96
well plates, followed by incubation at 25 °C for a further two days (ﬁve
days total). The samples were then observed by EM, which revealed
these to be densely populated by twisted, branched ﬁbers between
100 and 500 nm long (Fig. 7).4. Discussion
Here we demonstrate that the lag time for PLA2 acting on DPPC is
abolished at X=0.10 of PoxnoPC, together with an increase in the rate
and overall extent of hydrolysis revealed by a faster and more
pronounced decrement in pH. Oxidized phospholipids affect several
membrane properties including phase transition [62], lipid packing,
and dynamics [20,63], and water permeability, with the oxidatively
modiﬁed acyl chains extending out of the membrane [20,64]. These
changes can inﬂuence also the interactions of this phospholipid
derivative with small molecules and proteins [53,60]. Accordingly, it is
not unexpected that PoxnoPC changes the lag time of PLA2 acting on
DPPC.
Sevanian et al. [65–67] suggested that PLA2 may provide a
protective mechanism purging oxidized phospholipids from mem-
branes. However, the veriﬁcation of preferential hydrolysis of
oxidized phospholipids by PLA2 has been hampered by methodolog-
ical difﬁculties arising from determining the physical state of the
membrane as well as from determining the amount of free fatty acids
liberated from the membrane [68]. It was pointed out that it was not
discriminated whether the liberated fatty acids were predominantly
the peroxidized or the native species [68]. Pure oxidized phospholi-
pids are better substrates than native lipids. However, when oxidized
phospholipids are present together with native phospholipids this is
reversed with liberation of non-oxidized acyl chains being preferred
Fig. 7. Electron microscopy of PLA2 ﬁbers formed in the presence of PoxnoPC. PLA2 (3.8 µM ﬁnal concentration) was incubated for 24 h at room temperature (approx. 25 °C) with
10 µM PoxnoPC in 20 mM Hepes, 0.1 mM EDTA, pH 7.4. Scale bar corresponds to 0.2 µm.
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resulting in a faster accumulation of the products required for burst.
In addition to altered lipid organization and packing in the
presence PoxnoPC in a DPPC membrane, this oxidized phospholipid
could also directly interact and induce conformational changes in
PLA2 causing enhanced hydrolysis. PLA2 changes its conformation in
the presence of proper lipid interfaces, leading to oligomerization and
further to amyloid formation [32]. We have suggested that the
activation of PLA2 by its reaction products represents a novel type of
functional amyloid formation, with transient highly active intermedi-
ates and subsequent inactivation upon conversion to amyloid acting
as a very secure thermodynamic on-off switch controlling the activity
of this potentially lethal enzyme. Approximately X=0.08 of reaction
products are needed for the burst in activity, these lipids segregated
into a microdomains causing PLA2 aggregation [31]. As the hydro-
philic aldehyde moiety at the end of the oxononanoyl chain at sn-2
position in glycerol loops back and is accommodated into the
interface, the effective shape of PoxnoPC becomes conical, resembling
lysoPC. Accordingly, both lysoPC as well as PoxnoPC promote positive
spontaneous membrane curvature, in particular when enriched into
microdomains. To this end while the underlying mechanism is
unclear, positive curvature has been shown to promote amyloid
formation [70,71]. Also domain boundaries could be involved in
promoting the activation of PLA2 [16,72,73]. These boundaries
represent packing defects and would be expected to accommodate
membrane partitioning impurities such as PLA2. As a consequence
PLA2 would line up in the lipid surface along the domain boundaries
and become arranged into pseudo 1-dimensional arrays, promoting
oligomerization. Solid DPPC domains observed in monolayers by
ﬂuorescence microscopy become smaller and more numerous with
increasing XPoxnoPC [20], resulting in an increased boundary length.
The single primary aldehyde group of the PoxnoPC oxononanoyl
can react with a primary amino group of a protein e.g. lysine acting as
a nucleophile by forming Schiff's adducts as reported for a number of
in vivo aldehydic products of lipid peroxidation, malondialdehyde,
secosterols [74–76], 4-hydroxynonenal [14,75–77], and PoxnoPC
[50,53]. Oxidative products may rapidly change the function of a
protein such as 4-hydroxynonenol triggering disease-associated
protein misfolding by reacting with the lysines of α-synuclein or
Aβ-peptide [74]. Likewise, isoprostanes forming γ-isoketals rapidly
cross-link potassium channel proteins, inhibiting its function [78].
Due to chain reversal upon the oxidatively modiﬁed chain
adopting the extended conformation the aldehyde group of PoxnoPC
becomes exposed to the aqueous phase [20,53]. The reactive aldehyde
moiety is exposed in both the DPPC membrane, at submicellar
concentrations of PoxnoPC, and after hydrolysis of PoxnoPC by PLA2.
In the current study we did not determine if it is PoxnoPC or DPPC,
which is preferentially cleaved by PLA2. In either scenario the reactive
aldehyde moiety would be able to react with PLA2. Blocking thealdehyde group with methoxyamine abolishes the scattering for PLA2
induced by PoxnoPC (Fig. 4). Both PoxnoPC and free oxononanoyl
chain may form a Schiff base with e.g. lysine residues on the surface of
PLA2, present in the interfacial region of PLA2, and suggested to
interact with membranes[55]. Modiﬁcation of these residues may
promote PLA2 oligomerization. The cross-linking of the PLA2 at its
lysine residues has been previously demonstrated to lead to
irreversible activation [79]. We propose that PoxnoPC forms a
transient Schiff base with PLA2, inducing aggregates that trap PLA2
into transient highly reactive protoﬁbril intermediates increasing the
overall activity [32,35]. The above mechanism is supported by
experiments in which PoxnoPC is preincubated with PLA2, causing a
signiﬁcant increase in the overall amount of products generated upon
the hydrolysis of a pyrene labeled phospholipid substrate (Fig. 3).
Fibrillar aggregates of PLA2 form in the presence of PoxnoPC (Fig. 7).
LysoPC has been shown to induce PLA2 aggregation [30] and to
activate it decreasing the lag time [31]. Interestingly, preincubation of
PLA2 with submicellar concentrations of lysoPC decreases the PLA2
activity (Fig. 3), in keeping with recent reports on the inhibition of
PLA2 by lysoPC at submicellar concentrations [80]. Both lysoPC and
PoxnoPC below CMC show an increase in ThT ﬂuorescence intensity
indicating the formation of protoﬁbrils or ﬁbrillar aggregates by PLA2
(Fig. 6). Similar results have been obtained with short chain lipids and
apolipoprotein CII [81], with hydrophobic interactions being respon-
sible for the partial unfolding of the latter peptide [59].
Evidence for the formation of large complexes comes from micros-
copy, demonstrating the formation of Thioﬂavin T stained macroscopic
ﬁbres, in keeping with our previous results [35,48]. Upon examination of
a large number of EM pictures we observed the ﬁbers to be in 100–
500 nm long, branched, and twisted, differing in size and characteristics
from the ﬁbrils in the absence of PoxnoPC [35,48]. Our results are
consistent with EM pictures of other peptides and proteins that form
amyloid ﬁbrils viz. glucagon [82], IAPP [83], and apolipoprotein CII [84].
The formation of a PLA2 aggregate was also suggested by FRET data
using PLA2 labeled with either a donor or an acceptor [48]. Reports on
FRET for amyloid ﬁbres are lacking from literature and this complies
withourownﬁndings [48],wherewe couldonlydetect a transient FRET.
Notably, lack of FRET is compatible with the high degree of order in
amyloid ﬁbrils, which causes excitation delocalization. At high dye
concentrations and in an ordered structure the extent of excitation
migration can be appreciable. The migration of the excitation energy
fromone dyemolecule to anotherwith a different orientation e.g. donor
to acceptor causes a partial loss of polarization of the excited state. The
overall polarization loss arises from the fact that FRET tends to
randomize the distribution of orientations of the absorption dipole
moments of the molecules in the S1 state. If the intersystem crossing
rate exceeds the FRET rate [85], the excited molecules will populate the
triplet statewithout participating in FRET, thereby causing a loss of FRET
(Fig. 5).
1599C. Code et al. / Biochimica et Biophysica Acta 1798 (2010) 1593–1600Interestingly, oxidized lipids are present in submicromolar concen-
trations in vivo in blood plasma at sites of inﬂammation [4]. Oxidized
phospholipids partition less efﬁciently intomembranes because of their
augmented hydrophilicity [20,60]. PoxnoPC at submicellar concentra-
tions is a more efﬁcient inducer of ﬁbrillation than at the CMC (Fig. 6).
This is likely to be due to the hydrophobic nature of the premicellar
PoxnoPC aggregates, promoting hydrophobic contacts between PLA2
and this lipid. A Schiff base is likely to initiate theoligomerization (Fig. 4)
yet the hydrophobic interactions would be needed to stabilize the
oligomer into retaining PLA2 in a highly active state. We propose that
while lysoPC induces oligomer formation it also promotes its further
rapid transformation into inactive amyloid ﬁbrils, causing a shorter
lifetime for the active oligomer, before inactivation. These two lipids
thus promote PLA2 oligomerization via different pathways in the
protein folding/aggregation free energy landscape. Oxidized phospho-
lipids may act as an activating trigger for PLA2 in the development of
acute pancreatitis, for instance [9,86], with augmented inﬂammation
leading to cell damage and tissue edema. Patients with neurological
disorders like Alzheimer's and Parkinson's have increased levels of PLA2
alongwith an increased lipid peroxidation [87]. Chlorpromazine, a PLA2
inhibitor decreased the mortality in experimental pancreatitis in pigs
[86]. Oxidized phospholipids may well be direct targets for chlorprom-
azine and other antipsychotics [60]. These lipophilic drugs may thus
impart a dual effect in binding oxidized phospholipids and inhibiting
PLA2 by direct interaction, both mechanisms perhaps contributing to
the therapeutic outcome.
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